Table 4: Effects of WEFM, WEGT, and four marker compounds on chelating activity and tyrosinase inhibition.

Samples ( 𝜇 g/mL)Chelating activity Tyrosinase inhibition
(%)(%)

WEFM50 2 0 . 1 ± 1 . 7 2 6 . 3 ± 1 . 7
100 3 8 . 3 ± 0 . 7 4 5 . 8 ± 0 . 8
WEGM50 1 0 . 9 ± 1 . 8 1 1 . 7 ± 2 . 0
100 1 6 . 8 ± 1 . 1 1 8 . 9 ± 1 . 6
Daidzin50 4 4 . 6 ± 2 . 2 2 0 . 6 ± 1 . 6
100 7 5 . 8 ± 2 . 7 3 5 . 8 ± 0 . 7
Daidzein50 5 2 . 0 ± 0 . 8 3 0 . 8 ± 1 . 2
100 7 7 . 8 ± 2 . 1 5 5 . 8 ± 1 . 4
Genistin50 3 0 . 7 ± 1 . 1 2 8 . 6 ± 2 . 2
100 4 8 . 8 ± 0 . 6 5 3 . 3 ± 0 . 9
Genistein50 2 7 . 3 ± 1 . 4 3 3 . 1 ± 1 . 4
100 4 2 . 6 ± 2 . 6 5 8 . 6 ± 0 . 8

The data were displayed with mean ± S.D. of three experiments individually and analyzed by ANOVA ( 𝑃 < 0 . 0 5 ).